Eurospital Diagnostic Division | Eurospital Spa products

At the beginning of the nineties, the antigliadin antibody assay (AGA) was first used in studies on the prevalence and incidence of celiac disease. Before those studies, this disease was considered to be rare and its incidence was underestimated (1:1000/2000). Later, the study carried out at the University of Ancona showed a much higher prevalence (1:183) thereby revolutionising the knowledge on the disease and redefining its actual extent. The discovery of antiendomysium antibodies and, later, the anti-transglutaminase antibodies played down the role that these antibodies have in celiac disease diagnosis.

The knowledge about coeliac disease has increased a lot during last years. This has been possible due to the availability of new and more specific in vitro diagnostic medical devices.

The identification of tissue transglutaminase as the antigen responsible for endomysial positivity has opened up new horizons for the serological diagnosis of celiac disease. Today the determination of anti-tTG antibodies is the reference test for the diagnosis and follow-up of this disease.

Rapid monotest for the determination of IgA anti-transglutaminase and antigliadin antibodies in human serum.

Xeliac Test Professional is a rapid, simple and reliable test for the qualitative detection of IgA and IgG anti-tTG antibodies from a fingertip blood sample.